ILIAS Biologics ILIAS Therapeutics

(주)셀렉스라이프사이언스

News

ILIAS is the Leader of Next-Generation Exosome Therapeutics.

[ENG] 보도자료

ILIAS Biologics with world's best exosome technology, developing new drug for Sepsis and Gaucher's disease

페이지 정보

  • 작성자 : ILIAS Biologics
  • 작성일 : 19-05-10 15:47
  • 조회 : 245회

본문

 

14 Feb 2019


CEO of ILIAS Biologics interviewed by The Korea Economic Daily.


Exosome is highlighted as a novel drug delivery system recently. Dr. Chulhee Choi developed unique technology for therapeutic cargo loading in exosome lumen and established ILIAS Biologics Inc.(formerly known as Cellex Life Sciences) in South Korea.

 

Press Link (Korean) : https://www.hankyung.com/it/article/2019021486331
 

개인정보취급방침

닫기

이메일주소무단수집거부

닫기

사이트맵

사이트맵

몬트리올의정서
국내이행법령
사업안내
특정물질 수출입
알림·자료실
민원서비스
닫기